ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

MiR-193-3p inhibits the malignant progression of atherosclerosis by targeting WDR5.

Kai Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.